Esta tradução está a ser preparada. Entretanto, mostramos temporariamente a versão original em inglês.
Negócios · 13/12/20111 min de leitura
Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing the availability of a draft report entitled "Quantitative Summary of the Benefits and Risks of Prescription Drugs: A Literature Review" (literature review report). A literature review was conducted to address a requirement of the Patient Protection and Affordable Care Act (Affordable Care Act). FDA is publishing the literature review report to allow the public to provide comment on the report as it relates to the Affordable Care Act.
Idioma original da fonte: Federal Register — Health and Human ServicesAbrir o comunicado original →